Le Lézard
Classified in: Health, Business
Subject: DIV

K-Bro Declares September 2019 Dividend


(TSX: KBL)

EDMONTON, Sept. 13, 2019 /CNW/ - K-Bro Linen Inc. (the "Corporation") announced today a dividend of 10.00 cents CDN per common share of the Corporation for the period from September 1 to 30, 2019, to be paid on October 15, 2019 to holders of record of common shares on September 30, 2019.

The Corporation's policy is for shareholders of record on the last business day of a calendar month to receive dividends during the fifteen days following the end of such month.  K-Bro designates this dividend as an eligible dividend pursuant to subsection 89(14) of the Income Tax Act (Canada) and similar provincial and territorial legislation.

CORPORATE PROFILE

K-Bro is the largest owner and operator of laundry and linen processing facilities in Canada. K-Bro provides a comprehensive range of general linen and operating room linen processing, management and distribution services to healthcare institutions, hotels and other commercial accounts.  K-Bro currently operates nine processing facilities under three distinctive brands, including K-Bro Linen Systems Inc., Buanderie HMR and Les Buanderies Dextraze, in eight Canadian cities: Québec City, Montréal, Toronto, Edmonton, Calgary, Regina, Vancouver and Victoria.

Fishers was established in 1900 and is an operator of laundry and linen processing facilities in Scotland, providing linen rental, workwear hire and cleanroom garment services to the hospitality, healthcare, manufacturing and pharmaceutical sectors. Fishers' client base includes major hotel chains and prestigious venues across Scotland and the North East of England. The company operates seven sites, including one depot, in Scotland and the North East of England with facilities in Cupar, Perth, Newcastle, Livingston, Inverness and Coatbridge.

Additional information regarding the Corporation including required securities filings are available on our website at www.k-brolinen.com and on the Canadian Securities Administrators' website at www.sedar.com; the System for Electronic Document Analysis and Retrieval ("SEDAR").

K?Bro est le plus important propriétaire et exploitant de buanderies au Canada. K?Bro fournit une gamme étendue de services de buanderie aux établissements de soins de santé, hôtels et autres clients commerciaux. K?Bro exploite actuellement neuf usines sous trois marques distinctives, incluant K-Bro Linen Systems Inc., Buanderie HMR et Les Buanderies Dextraze, dans huit villes canadiennes: Québec, Montréal, Toronto, Edmonton, Calgary, Regina, Vancouver et Victoria.

Vous pouvez obtenir des renseignements supplémentaires sur la Société, y compris les documents déposés auprès des autorités de réglementation, sur notre site Web, au www.k-brolinen.com et sur le site Web des autorités canadiennes en valeurs mobilières au www.sedar.com, le site Web du Système électronique de données, d'analyse et de recherche (« SEDAR »).

SOURCE K-Bro Linen Inc.


These press releases may also interest you

at 03:00
Noted actor Laurence Fishburne is using his performance skills and gravitas for informative purposes as host of the television show "Behind the Scenes". This educational show aims to help its audience understand the challenges facing society today...

at 02:44
Fourth time in Chengdu, the 6th World Nobel Laureate Biomedical Summit, entitled "Artificial Intelligence and Brain Science: From the Bench to Human Applications and Industry Development", has invited 6 Nobel laureates, over 10 Chinese and foreign...

at 01:00
On average, 130 Americans die every day from an opioid overdose, including prescription and illicit drugs, according to the Centers for Disease Control and Prevention. The Baldwin County Community Alliance (BCCA) will unveil its newest tool to fight...

at 00:00
A-to-Zen Cosmetic Surgery & Aesthetics, a leading medical spa in Bellevue, WA offering the highest level of both plastic surgery and non-surgical aesthetic treatments, has expanded its menu with SkinPen® microneedling, the world's first FDA-cleared...

21 sep 2019
CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced results from the microsatellite instability high/deficient mismatch repair (MSI-H/dMMR) solid tumor cohort in the GEMSTONE-101 Phase Ib study of the Company's...

21 sep 2019
CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced preliminary results from the Phase Ia trial of the Company's anti-CTLA-4 antibody in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical...



News published on 13 september 2019 at 16:01 and distributed by: